BioNTech posts $721m loss in 2024 due to low demand for COVID-19 vaccines

German biotech firm BioNTech reported a loss of €665.3 million ($721 million) in 2024, as demand for its COVID-19 vaccines fell, according to the company’s financial results report on Monday.

The company, which posted a €930.3 million profit in 2023, failed to make a profit in a fiscal year…

Continue Reading


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *